Expertise in
1
conditions

Stephanie Carel-Cartalat

Lyon, FR 
Expertise in
1
conditions
Lyon, FR 

Overview

Stephanie Carel-Cartalat practices practicing medicine in Lyon, France.

Ms. Carel-Cartalat is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Glioma, Gliomatosis Cerebri, Glioblastoma, and Astrocytoma.

She is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Lyon, France
Other Locations
Bron, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Role of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Patients Wih Leptomeningeal Metastasis of Breast Cancer. A Randomized Phase III Study.
Role of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Patients Wih Leptomeningeal Metastasis of Breast Cancer. A Randomized Phase III Study.
Enrollment Status: Completed
Publish Date: June 12, 2019
Intervention Type: Drug
Study Phase: Phase 3
Secondary Prophylaxis Use of Romiplostim for the Prevention of Thrombocytopenia Induced by Temozolomide in Newly Diagnosed Glioblastoma Patients
Secondary Prophylaxis Use of Romiplostim for the Prevention of Thrombocytopenia Induced by Temozolomide in Newly Diagnosed Glioblastoma Patients
Enrollment Status: Terminated
Publish Date: April 25, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

9 Total Publications

TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study.
TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study.
Journal: The oncologist
Published: January 11, 2021

Frequently Asked Questions about Stephanie Carel-Cartalat

Is Stephanie Carel-Cartalat a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Stephanie Carel-Cartalat is classified as an Advanced expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stephanie Carel-Cartalat participate in research or clinical trials?

Yes. Stephanie Carel-Cartalat has published 9 articles and abstracts on conditions like Glioma. You can view a list of Stephanie Carel-Cartalat's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Carel-Cartalat's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile